Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Nature Reviews Neuroscience

• Publication date

  2019-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41583-019-0132-6PMID 30737462PMCID PMC9382875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of brain vasculature in neurodegenerative disorders

  2018cited by this paper
• Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study

  2018cited by this paper
• Specific binding of PCBP1 to heavily oxidized RNA to induce cell death

  2018cited by this paper
• Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis

  2018cited by this paper
• Ergothioneine – a diet‐derived antioxidant with therapeutic potential

  2018cited by this paper
• Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease.

  2018cited by this paper
• Transcriptional mutagenesis mediated by 8-oxoG induces translational errors in mammalian cells

  2018cited by this paper
• Glycation affects fibril formation of Aβ peptides

  2018cited by this paper
• Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease

  2018cited by this paper
• Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention

  2018cited by this paper
• Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment

  2018cited by this paper
• MRI-Based Screening of Preclinical Alzheimer’s Disease for Prevention Clinical Trials

  2018cited by this paper
• Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

  2018cited by this paper
• Alzheimer disease: APOE ε4 affects cognitive decline but does not block benefits of healthy lifestyle

  2018cited by this paper
• Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease

  2018cited by this paper
• Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial

  2018cited by this paper
• mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease‐like dementia

  2018cited by this paper
• Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach

  2018cited by this paper
• Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing

  2018cited by this paper
• Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP

  2018cited by this paper
• Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease

  2018cited by this paper
• Nutrition and prevention of cognitive impairment.

  2018cited by this paper
• Redox proteomics and amyloid β‐peptide: insights into Alzheimer disease

  2018cited by this paper
• Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

  2018cited by this paper
• Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease

  2018cited by this paper
• Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.

  2018cited by this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cited by this paper
• High performance plasma amyloid-β biomarkers for Alzheimer’s disease

  2018cited by this paper
• Exosomal biomarkers in Down syndrome and Alzheimer's disease

  2018cited by this paper
• SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease

  2017cited by this paper
• Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

  2017cited by this paper
• Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy.

  2017cited by this paper
• Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

  2017cited by this paper
• Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care)

  2017cited by this paper
• Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology

  2017cited by this paper
• The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics

  2017cited by this paper
• A cross‐sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease

  2017cited by this paper
• Role of 4‐hydroxy‐2‐nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age‐related neurodegenerative disorders

  2017cited by this paper
• HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.

  2017cited by this paper
• Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

  2017cited by this paper
• Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease

  2017cited by this paper
• Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation

  2017cited by this paper
• Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

  2017cited by this paper
• Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

  2017cited by this paper
• Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.

  2017cited by this paper
• The Essential Medicinal Chemistry of Curcumin

  2017cited by this paper
• Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease

  2017cited by this paper
• Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease

  2017cited by this paper
• Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate

  2017cited by this paper
• Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease

  2016cited by this paper
• Defeating Alzheimer's disease and other dementias: a priority for European science and society.

  2016cited by this paper
• Protein oxidation and peroxidation

  2016cited by this paper
• The Proteasome and Oxidative Stress in Alzheimer's Disease

  2016cited by this paper
• Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis

  2016cited by this paper
• Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.

  2016cited by this paper
• Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics

  2016cited by this paper
• Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD

  2015cited by this paper
• Measurement of oxidatively induced DNA damage and its repair, by mass spectrometric techniques

  2015cited by this paper
• Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1/BVR-A System: Insights for Transition to Alzheimer's Disease

  2015cited by this paper
• Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.

  2015cited by this paper
• α-Tocopherol supplementation reduces 5-nitro-γ-tocopherol accumulation by decreasing γ-tocopherol in young adult smokers*

  2015cited by this paper
• The isoprostanes--25 years later.

  2015cited by this paper
• Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w.

  2015cited by this paper
• Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease.

  2015cited by this paper
• Tracking the earliest pathologic changes in Alzheimer disease

  2014cited by this paper
• Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.

  2014cited by this paper
• The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

  2014cited by this paper
• Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives.

  2014cited by this paper
• Oxidative Stress and Proteostasis Network: Culprit and Casualty of Alzheimer’s-Like Neurodegeneration

  2014cited by this paper
• The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.

  2014cited by this paper
• Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

  2014cited by this paper
• Vitamin E is essential for Purkinje neuron integrity.

  2014cited by this paper
• Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation.

  2014cited by this paper
• Mitochondrial biogenesis: pharmacological approaches.

  2014cited by this paper
• Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.

  2013cited by this paper
• Exercise counteracts declining hippocampal function in aging and Alzheimer's disease.

  2013cited by this paper
• Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

  2013cited by this paper
• Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease

  2013cited by this paper
• Neurological phenotypes for Down syndrome across the life span.

  2012cited by this paper
• Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2

  2012cited by this paper
• Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations

  2012cited by this paper
• Biliverdin reductase‐A: a novel drug target for atorvastatin in a dog pre‐clinical model of Alzheimer disease

  2012cited by this paper
• Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

  2012cited by this paper
• Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid

  2011cited by this paper
• Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

  2011cited by this paper
• Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media.

  2010cited by this paper
• Neuropathologic Alterations in Mild Cognitive Impairment: A Review

  2010cited by this paper
• Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease.

  2010cited by this paper
• Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

  2009cited by this paper
• APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

  2009cited by this paper
• Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.

  2009cited by this paper
• RNA oxidation in Alzheimer disease and related neurodegenerative disorders

  2009cited by this paper
• Proteomic identification of nitrated brain proteins in early Alzheimer’s disease inferior parietal lobule

  2009cited by this paper
• Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease

  2008cited by this paper
• Aβ inhibits the proteasome and enhances amyloid and tau accumulation

  2008cited by this paper
• Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.

  2008cited by this paper
• Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

  2008cited by this paper
• Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.

  2008cited by this paper
• Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

  2007cited by this paper
• REVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E

  2007cited by this paper

• Self-Assembled Rg3/Naringenin Nanoparticles for Targeted Brain Delivery: A Promising Therapeutic Approach for Early Alzheimer’s Disease

  2026cites this paper
• Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases

  2026cites this paper
• Exercise Suppresses Insulin Resistance: A Potential Mechanism for Improving the Interaction Between Type 2 Diabetes and Alzheimer's Disease.

  2026cites this paper
• Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology

  2026cites this paper
• In vitro investigation of miR-206-3p-loaded extracellular vesicles as modulators of Aβ-induced neurodegeneration.

  2026cites this paper
• The Potential of Exhaled Breath Analysis for Alzheimer's Disease Monitoring (mini review).

  2026cites this paper
• Ultrasound‐enhanced delivery of donepezil and poly (β‐amino ester) nanoparticles via astrocyte‐derived exosomes in promoting amyloid‐β clearance and supporting neuronal regeneration

  2026cites this paper
• Nonlinear dynamic genetic regulation identifies peripheral drivers of neurodegenerative disease progression

  2026cites this paper
• Curcumin Rescues Oxidative Stress-Induced Impairment of PINK1/Parkin Pathway-Mediated Mitophagy in APOE4-Expressing Astrocytes

  2026cites this paper
• SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients.

  2026cites this paper
• Implication of xanthine oxidoreductase in oxidative stress-related chronic diseases

  2026cites this paper
• A new paradigm for stratified cognitive assessment: fusing serum Raman spectroscopy and ensemble learning

  2026cites this paper
• The Role of Oxidative Stress and Total Antioxidant Capacity in the Management of Impacted Third Molars: A Narrative Review

  2026cites this paper
• Tracking neurological diseases: advances in fluorescent probes design and application

  2026cites this paper
• Ultramicronized palmitoylethanolamide restores astrocyte-neuron metabolic coupling and Klotho/FGF21 signaling in a triple-transgenic mouse model of Alzheimer's disease.

  2026cites this paper
• Effects of Letrozole Administration on Metabolic, Inflammatory, and Oxidative Responses in Rat Serum and Brain Tissue

  2026cites this paper
• Bridging pathway dysfunction and therapy: novel compounds for neuroprotection

  2026cites this paper
• GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study.

  2026cites this paper
• Body-Wide Glycolytic Shift, Oxidative Stress, and Sex-Specific Effect of Caloric Restriction in a Mouse Model of Alzheimer's Disease.

  2026cites this paper
• Deuterated Polyunsaturated Fatty Acids Alleviate In Vitro Skeletal Muscle Dysfunction Induced by Oxidative Stress.

  2026cites this paper
• Neuroprotective Effects of Citropten Against Scopolamine-Induced Cognitive Impairment and Oxidative Stress in a Rat Model

  2026cites this paper
• Insulin-like growth factor 1 associated research in Alzheimer’s disease: an exploratory trends analysis

  2026cites this paper
• Chiral ZnO Nanoparticles Synergistically Inhibiting Fibrillization and Disaggregating of Amyloid-β Fibrils for Attenuation Neurotoxicity

  2026cites this paper
• Mechanism, measurement and significance of oxidative DNA damage- a tribute to Miral Dizdaroglu.

  2026cites this paper
• Longitudinal Analysis of Mitochondrial D-Loop Methylation and Copy Number in Peripheral Blood: Epigenetic Signatures of Alzheimer’s Disease Progression and Aging

  2026cites this paper
• Neurochemical memory diversification towards liquid reinforcement learning

  2026cites this paper
• Comprehensive metabolic profiling across five lifespan stages in murine hippocampus and cortex reveals sex-related variation in age-related cognitive decline

  2026cites this paper
• Fructan PKP-1b from Polygonatum kingianum attenuates aging and neurodegeneration by inhibiting insulin/IGF-1 signaling.

  2026cites this paper
• Extracellular Vesicles in Alzheimer’s Disease: Dual Roles in Pathogenesis, Promising Avenues for Diagnosis and Therapy

  2026cites this paper
• Reactive oxygen species in exercise biology: from adaptive stress response to cell signaling and beyond.

  2026cites this paper
• Disordered sphingolipid metabolism mediates cognitive impairment in juvenile mice on a high-glucose diet

  2026cites this paper
• Brain Glutathione Levels Associate With Cognitive Performance in Older Adults

  2026cites this paper
• Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer’s Disease and Related Dementia

  2026influential citation
• Energetic implications of fMRI-based nodal complex network metrics: a complex picture unfolds across diverse brain states

  2026cites this paper
• Semaglutide Attenuates Neuroinflammation in Mice

  2026cites this paper
• Isovanillin-derived bis-hydrazones as dual cholinesterase and carbonic anhydrase inhibitors: synthesis, enzymatic profiling, and computational insights from molecular docking and dynamics.

  2026cites this paper
• Two advanced-aged patients with diabetic striatopathy: a case report and literature review

  2026cites this paper
• An integrative multi-omics study reveals glutamine metabolism dysregulation connecting Alzheimer's disease and age-related macular degeneration.

  2026cites this paper
• Dietary and metabolic reprogramming alleviates neurodegeneration: a review of mechanisms and clinical implications

  2026cites this paper
• Mechanistic advances in exercise-mediated regulation of autophagy dysfunction in Alzheimer's disease (Review)

  2026cites this paper
• Molecular sabotage of hippocampal synaptic plasticity by amyloid-β in Alzheimer's disease: A narrative review

  2026cites this paper
• Therapeutic Potential of Amyloid‐β Interactors in Rapidly Progressive Alzheimer's Disease—An In Silico Study

  2026cites this paper
• The association between inflammation biomarkers with mental and behavioral disorders due to use of tobacco: a cross-section and cohort study.

  2026cites this paper
• Nutrition for older adults: Perspectives on dietary guidance for healthy aging

  2026cites this paper
• Metabolic dysfunction and mitochondrial failure in Alzheimer's disease: integrating pathophysiology, clinical evidence and emerging interventions

  2026cites this paper
• CM-TRAP: A Chemoproteomic Workflow for Profiling Circulating Metabolites and Their Protein Targets in Alzheimer's Disease

  2026cites this paper
• Insulin Resistance as a Shared Pathophysiological Driver in Neurological Disorders: a Narrative Review

  2026cites this paper
• CD4+T cell metabolic reprogramming as therapeutic targets in neurodegenerative diseases.

  2026cites this paper
• Post‐translational regulation of human D‐3‐phosphoglycerate dehydrogenase in Alzheimer's disease

  2026cites this paper
• Allele-specific splicing modulates protein isoforms and Alzheimer’s risk

  2026cites this paper
• Reactive oxygen species-activated bioorthogonal chemistry in living systems enabled by boronate-caged dihydrotetrazines.

  2026cites this paper
• Intelliwaste: NMR of 13C-labeled Spent Media Enables Non-Invasive Metabolic Fingerprinting of Pluripotent Stem Cells and LIS1-Associated Neuropathology

  2026cites this paper
• Preliminary study of polyethylene microplastics disrupting energy Metabolism, redox Balance, and prefrontal cortex structure in Wistar rats

  2026cites this paper
• Advances in Alzheimer's disease: mechanistic insights and therapeutic targets.

  2026cites this paper
• Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory/inhibitory imbalance, and sleep loss

  2026cites this paper
• From Limb to Brain: Lymphedema as a Systemic Disease with Metabolic, Immunological, and Neurodegenerative Consequences and the Disease-Modifying Potential of Lymphaticovenous Anastomosis—An Integrative Analysis

  2026cites this paper
• Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes

  2026cites this paper
• Innovative public-health strategies for neurodegenerative disease: leveraging diversified ultraviolet irradiation as a next-generation therapy.

  2026cites this paper
• Amyloid-ID: photocatalytic profiling of amyloid deposits in Alzheimer’s disease tissue

  2026cites this paper
• The Emerging Role of L-Arginine and Creatine Supplementation Combined with Exercise on Hippocampal Neurogenesis, Spatial Learning, and Cognitive Flexibility in Aging and Neurodegenerative Diseases

  2026cites this paper
• The Molecular Architecture of Neurodegeneration: An Integrative Overview of Convergent Mechanisms

  2026cites this paper
• An integrated non-alkaline derivatization strategy using 2,2'-dithiodipyridine and HPLC for simultaneous analysis of total and low-molecular-weight free thiols in human serum.

  2025cites this paper
• Linkage of circadian rhythm disruptions with Alzheimer's disease and therapeutic interventions

  2025cites this paper
• Synergistic Neuroprotective Effects of Ergothioneine and Lactoferrin in APP/PS1 Transgenic Mice and Mouse N2a Cells.

  2025cites this paper
• Mechanisms of the Pathogenesis of Alzheimer’s Disease: The Role of the Basal Forebrain

  2025cites this paper
• Stress-related neurodegenerative diseases: Molecular mechanisms implicated in neurodegeneration and therapeutic strategies.

  2025cites this paper
• Plumbagin as a potential therapeutic agent for scopolamine-induced Alzheimer's disease: Mechanistic insights into GSK-3β inhibition.

  2025cites this paper
• Enhancement of cognitive benefits and anxiolytic effects of scoparone (6,7-dimethoxycoumarin) in a zebrafish (Danio rerio) model of scopolamine-induced anxiety and memory impairment

  2025cites this paper
• Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer’s Disease—Insights from In Vivo and In Vitro Studies

  2025cites this paper
• The many roads to dementia: a systems view of Alzheimer's disease

  2025cites this paper
• The mechanistic action of mogroside V in the alleviation of oxidative aging

  2025cites this paper
• Role of Glycerophospholipid Metabolism in Epilepsy.

  2025cites this paper
• Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases

  2025cites this paper
• Reducing Alzheimer's Disease Risk with SGLT2 Inhibitors: From Glycemic Control to Neuroprotection.

  2025cites this paper
• Estimation of oxygen extraction fraction based on hemodynamic measurements using DSC-MRI

  2025cites this paper
• Butyrate: a key mediator of gut-brain communication in Alzheimer’s disease

  2025cites this paper
• Polyphenol-regulated Cu-based broad-spectrum anti-oxidants to overcome oxidative stress

  2025cites this paper
• Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective

  2025cites this paper
• Transcriptional profile and quantitative proteomics revealed NGF-p75NTR-associated synaptic plasticity and heterogeneity for diabetic encephalopathy and the potential role of CoQ10 for diabetic induced cognitive deficits in mice.

  2025cites this paper
• Protective effects of alpha-lipoic acid on memory deficit induced by repeated doses of solifenacin in mice: the role of nitro-oxidative stress

  2025cites this paper
• Hemoglobin in the brain frontal lobe tissue of patients with Alzheimer’s disease is susceptible to reactive nitrogen species-mediated oxidative damage

  2025cites this paper
• 3-(3-(diethylamino)propyl)-2-(4-(methylthio)phenyl)thiazolidin-4-one Attenuates Scopolamine-induced Cognitive Impairment in Rats: Insights Into Neuroprotective Effects

  2025cites this paper
• Integrating network pharmacology and in vivo study to explore the anti-Alzheimer’s potential of Bergenia ligulata and Nelumbo nucifera

  2025cites this paper
• Gastrodin alleviates Aβ25-35-induced glycolytic dysfunction via activating PI3K/AKT/BACH1 signaling in Alzheimer's disease models.

  2025cites this paper
• Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages

  2025cites this paper
• Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.

  2025cites this paper
• A Review Article on Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Alzheimer’s Disease

  2025cites this paper
• Direct Quantification of Neuroprotective Effect of Single-Atom Catalyst on Neurochemical Transmission by Multi-Spatiotemporal Electrochemistry.

  2025cites this paper
• Neochlorogenic acid ameliorates Alzheimer's disease-like pathology via scavenging oxidative stress and restoring blood-brain barrier function in zebrafish.

  2025cites this paper
• A rice SOUL family heme-binding protein REAC1 enhances the antioxidative capacity of C. elegans through modulation of ROS-related gene expression

  2025cites this paper
• Efficacy of Plasmalogens on Monosodium Glutamate-Induced Neurotoxicity in Male Rats Through NF-κB and p38 MAPK Signaling Pathways

  2025cites this paper
• Grounding as a complementary intervention for Alzheimer's disease: Mechanisms, evidence, and potential therapeutic applications

  2025influential citation
• Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

  2025cites this paper
• Radix Hedysari Polysaccharides modulate the gut-brain axis and improve cognitive impairment in SAMP8 mice.

  2025cites this paper
• Exploring Erdr1-Mid1 Axis: Shared Risk Factors and Molecular Mechanisms in Aging and Degenerative Diseases

  2025cites this paper
• Gallic acid enhances memory, learning and reduces neuroinflammation in a rat model of scopolamine-induced cholinergic dysfunction

  2025cites this paper
• Hyperuricemia reduces the risk of MCI but not dementia: a cross-sectional study in Liuyang

  2025cites this paper
• Effects of oxidative stress and GDNF on patients with bipolar disorder: a prospective study

  2025cites this paper
• Rock inhibitors in Alzheimer’s disease

  2025cites this paper
• A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer's disease combination therapy.

  2025cites this paper